home / stock / cydy / cydy news

CYDY News and Press, CytoDyn Inc From 04/01/20

Stock Information
Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com
Menu
CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...
CYDY - Vaccine For COVID-19 Health Crises "Possible" By Summer After FDA Fast-Tracks Clinical Trials

April 1, 2020 Palm Beach, FL – April 1, 2020 – The World House has called on U.S. health regulators to expedite potential therapies aimed at treating COVID-19 amid the fast-spreading coronavirus outbreak, saying it could lead to a breakthrough while a vaccine is still un...
CYDY - COVID-19-related actions - healthcare

AbbVie (NYSE: ABBV ) donates $35M to support COVID-19 relief efforts. Shares down  2%  premarket. More news on: AbbVie Inc., Mallinckrodt plc, CytoDyn Inc., Healthcare stocks news, Stocks on the move, Read more ...

CYDY - CytoDyn Files a Clinical Trial Protocol with the FDA to Treat Severely Ill COVID-19 Patients with Leronlimab where the Primary Endpoint is Mortality Rate at Two Weeks

VANCOUVER, Washington, April 01, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announce...

CYDY - "Next Super Stocks" in News:  CYDY: Coronavirus Treatment Progress.  FBNK: fuboTV ($223 million run rate) Merger = Streaming Powerhouse. NEXCF: Remote Work/Learning Acquisition, Revenues Accelerating.

NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, is highlighting companies which recently presented at it’s NEXT SUPER STOCK investor conference series that are making news this week. FaceBank Group (OTC: FBNK) Merg...
CYDY - Over 35 Companies In Race To Develop Vaccine For COVID-19 Health Crises

March 31, 2020 Palm Beach, FL – March 31, 2020 – The World Health Organization has urged people and nations to avoid spreading the pathogen in the current global health crisis while the search for treatments continues at a its frenzied pace, but even at their most effect...

CYDY - CytoDyn completes $15M convertible debt offering

CytoDyn ( OTCQB:CYDY ) has completed a new non-dilutive convertible debt offering of $15M. More news on: CytoDyn Inc., Healthcare stocks news, , Read more ...

CYDY - FDA clears Cytodyn's mid-stage leronlimab trial for mild-to-moderately ill Covid-19 patients

CytoDyn ( OTCQB:CYDY ) announces that the FDA has provided clearance for initiation of a Phase 2 trial with leronlimab to treat COVID-19 patients with mild to moderate indications. More news on: CytoDyn Inc., Healthcare stocks news, Read more ...

CYDY - CytoDyn Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants

VANCOUVER, Washington, March 31, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announce...

CYDY - FDA Clears CytoDyn's Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately

VANCOUVER, Washington, March 31, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announce...

CYDY - Three Additional Patients with Severe COVID-19 Treated with Leronlimab in New York Medical Center Bringing the Total to 10 Patients

VANCOUVER, Washington, March 30, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announce...
Previous 10 Next 10